Itolerance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Itolerance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Itolerance Today - Breaking & Trending Today

iTolerance, Inc. and Kadimastem Enter into Collaboration Agreement for Development of a Potential Cure for Type 1 Diabetes and Receive US $1.0 Million Grant from the BIRD Foundation

MIAMI, FL / ACCESSWIRE / May 18, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine company developing technologies to enable tissue, organoid or cell therapy ....

Tel Aviv , United States , Anthony Japour , Jenene Thomas , Asaf Shiloni , Gewinn Nur , Susan Roberts , Tolerance Inc , Israel Innovation Authority , Tolerance Inc View , Tel Aviv Stock Exchange , Weizmann Institute Of Science , Binational Israel U , Chief Executive Officer , Human Embryonic Stem Cells , Professor Michel Revel , Professor Emeritus , Molecular Genetics , Weizmann Institute , Professor Revel , Israel Prize , Private Securities Litigation Reform Act , Inc View ,

iTolerance, Inc. Announces Issuance of U.S. Patent Covering Proprietary Regenerative SA-FasL Microgel Technology, iTOL-100

Company leveraging iTOL-100 to advance a pipeline of programs that have the potential to cure diseases, such as Type 1 Diabetes, without the need for life-long immunosuppressionMIAMI, FL / ACCESSWIRE / ....

United States , Jenene Thomas , Susan Roberts , Anthony Japour , Trademark Office , Tolerance Inc View , Tolerance Inc , Health Canada , United States Patent , L Engineered Biomaterials , Chief Executive Officer , Private Securities Litigation Reform Act , Inc View ,

iTolerance, Inc. CEO to Present at the Bio LaunchPad Seminar at Georgia Tech's Institute for Bioengineering and Bioscience

Livestream presentation to be held on Thursday, March 30, 2023 at 11:00 AM ETMIAMI, FL / ACCESSWIRE / March 29, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine ....

United States , Jenene Thomas , Susan Roberts , Anthony Japour , Tolerance Inc , University Of Louisville , Tolerance Inc View , Chief Executive Officer , Bio Launchpad Seminar , Georgia Tech , Private Securities Litigation Reform Act , Inc View , Diese Gold Aktie , Sichern Sie ,

iTolerance, Inc. Completes Pre-IND Meeting with U.S. FDA for Development Program as a Potential Cure for Type 1 Diabetes Without the Need for Life-long Immunosuppression

MIAMI, FL / ACCESSWIRE / March 1, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine company developing technologies to enable tissue, organoid or cell therapy ....

United States , Dennis Riedl , Anthony Japour , Jenene Thomas , Susan Roberts , Tolerance Inc View , Drug Administration , Tolerance Inc , Pre Investigational New Drug Application , Chief Executive Officer , Private Securities Litigation Reform Act , Inc View ,

iTolerance, Inc. Bolsters Leadership Team with Scientific, Development and Global Regulatory Affairs Expertise

Sumitra Ghate promoted to Senior Vice President of Development & Global Regulatory Affairs to continue driving strategic regulatory and development programsDr. Esma S. Yolcu appointed as Chief Technical ....

University Of Louisville , United States , Anthony Japour , Jenene Thomas , Dennis Hester , Kostenloser Wertpapierhandel , Sumitra Ghate , Sumitram Ghate , Susan Roberts , University Of Kansas , School Of Medicine , American Heart Association , Institute Of Clinical , American Diabetes Association , Development Global Regulatory Affairs , Translational Sciences , American Society Of Hematology , University Of Missouri , Washington University , Department Of Molecular Microbiology , American Society Of Transplantation , Regulatory Affairs , National Institutes Of Health , Department Of Microbiology Immunology , Tolerance Inc , School Of Medicine At Gazi University ,